These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 2350207

  • 1. Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa.
    Kaye WH, Berrettini W, Gwirtsman H, George DT.
    Arch Gen Psychiatry; 1990 Jun; 47(6):548-56. PubMed ID: 2350207
    [Abstract] [Full Text] [Related]

  • 2. Cerebrospinal fluid peptide YY immunoreactivity in eating disorders.
    Berrettini WH, Kaye WH, Gwirtsman H, Allbright A.
    Neuropsychobiology; 1988 Jun; 19(3):121-4. PubMed ID: 3200408
    [Abstract] [Full Text] [Related]

  • 3. Leptin, neuropeptide Y, and peptide YY in long-term recovered eating disorder patients.
    Gendall KA, Kaye WH, Altemus M, McConaha CW, La Via MC.
    Biol Psychiatry; 1999 Jul 15; 46(2):292-9. PubMed ID: 10418705
    [Abstract] [Full Text] [Related]

  • 4. Reduced gastrin releasing peptide in cerebrospinal fluid after recovery from bulimia nervosa.
    Frank GK, Kaye WH, Ladenheim EE, McConaha C.
    Appetite; 2001 Aug 15; 37(1):9-14. PubMed ID: 11562153
    [Abstract] [Full Text] [Related]

  • 5. [Selected issues of biological aspects of eating disorders].
    Włodarczyk-Bisaga K, Bisaga A.
    Psychiatr Pol; 1994 Aug 15; 28(5):579-91. PubMed ID: 7991711
    [Abstract] [Full Text] [Related]

  • 6. CSF oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiologic considerations.
    Demitrack MA, Lesem MD, Listwak SJ, Brandt HA, Jimerson DC, Gold PW.
    Am J Psychiatry; 1990 Jul 15; 147(7):882-6. PubMed ID: 2356873
    [Abstract] [Full Text] [Related]

  • 7. Neurochemistry of bulimia nervosa.
    Kaye WH, Weltzin TE.
    J Clin Psychiatry; 1991 Oct 15; 52 Suppl():21-8. PubMed ID: 1682306
    [Abstract] [Full Text] [Related]

  • 8. Lowered serum dipeptidyl peptidase IV activity in patients with anorexia and bulimia nervosa.
    van West D, Monteleone P, Di Lieto A, De Meester I, Durinx C, Scharpe S, Lin A, Maj M, Maes M.
    Eur Arch Psychiatry Clin Neurosci; 2000 Oct 15; 250(2):86-92. PubMed ID: 10853924
    [Abstract] [Full Text] [Related]

  • 9. Gonadotropin response to LH-RH in anorexia nervosa and bulimia.
    Kiriike N, Nishiwaki S, Nagata T, Maeda Y, Kawakita Y.
    Acta Psychiatr Scand; 1988 Apr 15; 77(4):420-6. PubMed ID: 2839011
    [Abstract] [Full Text] [Related]

  • 10. Plasma leptin, neuropeptide Y (NPY) and galanin concentrations in bulimia nervosa and in anorexia nervosa.
    Baranowska B, Wolinska-Witort E, Wasilewska-Dziubinska E, Roguski K, Chmielowska M.
    Neuro Endocrinol Lett; 2001 Oct 15; 22(5):356-8. PubMed ID: 11600878
    [Abstract] [Full Text] [Related]

  • 11. CSF somatostatin in anorexia nervosa and bulimia: relationship to the hypothalamic pituitary-adrenal cortical axis.
    Kaye WH, Rubinow D, Gwirtsman HE, George DT, Jimerson DC, Gold PW.
    Psychoneuroendocrinology; 1988 Oct 15; 13(3):265-72. PubMed ID: 2900533
    [Abstract] [Full Text] [Related]

  • 12. A review of neuropeptide and neuroendocrine dysregulation in anorexia and bulimia nervosa.
    Bailer UF, Kaye WH.
    Curr Drug Targets CNS Neurol Disord; 2003 Feb 15; 2(1):53-9. PubMed ID: 12769812
    [Abstract] [Full Text] [Related]

  • 13. Neuropeptide Y and Peptide YY in Association with Depressive Symptoms and Eating Behaviours in Adolescents across the Weight Spectrum: From Anorexia Nervosa to Obesity.
    Tyszkiewicz-Nwafor M, Jowik K, Dutkiewicz A, Krasinska A, Pytlinska N, Dmitrzak-Weglarz M, Suminska M, Pruciak A, Skowronska B, Slopien A.
    Nutrients; 2021 Feb 11; 13(2):. PubMed ID: 33670342
    [Abstract] [Full Text] [Related]

  • 14. Central and peripheral ACTH and cortisol levels in anorexia nervosa and bulimia.
    Gwirtsman HE, Kaye WH, George DT, Jimerson DC, Ebert MH, Gold PW.
    Arch Gen Psychiatry; 1989 Jan 11; 46(1):61-9. PubMed ID: 2535925
    [Abstract] [Full Text] [Related]

  • 15. Contribution of CNS neuropeptide (NPY, CRH, and beta-endorphin) alterations to psychophysiological abnormalities in anorexia nervosa.
    Kaye WH, Berrettini WH, Gwirtsman HE, Gold PW, George DT, Jimerson DC, Ebert MH.
    Psychopharmacol Bull; 1989 Jan 11; 25(3):433-8. PubMed ID: 2533990
    [Abstract] [Full Text] [Related]

  • 16. [Peptide YY and neuropeptide Y in the intestine: availability, biologic effects and epithelial receptors].
    Laburthe M.
    Arch Int Physiol Biochim Biophys; 1991 Sep 11; 99(5):A177. PubMed ID: 1720689
    [No Abstract] [Full Text] [Related]

  • 17. Effect of estrogen or insulin-induced hypoglycemia on plasma oxytocin levels in bulimia and anorexia nervosa.
    Chiodera P, Volpi R, Capretti L, Marchesi C, d'Amato L, De Ferri A, Bianconi L, Coiro V.
    Metabolism; 1991 Nov 11; 40(11):1226-30. PubMed ID: 1943752
    [Abstract] [Full Text] [Related]

  • 18. CSF oxytocin and vasopressin levels after recovery from bulimia nervosa and anorexia nervosa, bulimic subtype.
    Frank GK, Kaye WH, Altemus M, Greeno CG.
    Biol Psychiatry; 2000 Aug 15; 48(4):315-8. PubMed ID: 10960163
    [Abstract] [Full Text] [Related]

  • 19. Editorial: from gut to mind--hormonal satiety signals and anorexia nervosa.
    Chaudhri OB, Field BC, Bloom SR.
    J Clin Endocrinol Metab; 2006 Mar 15; 91(3):797-8. PubMed ID: 16522706
    [No Abstract] [Full Text] [Related]

  • 20. Central and peripheral peptides regulating eating behaviour and energy homeostasis in anorexia nervosa and bulimia nervosa: a literature review.
    Tortorella A, Brambilla F, Fabrazzo M, Volpe U, Monteleone AM, Mastromo D, Monteleone P.
    Eur Eat Disord Rev; 2014 Sep 15; 22(5):307-20. PubMed ID: 24942507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.